EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid – cross-over trials in Ronneby, Sweden

Axel G Andersson, Yiyi Xu, Anna Kärrman, Julia Cederlund, Christian H Lindh, Daniela Pineda, Tony Fletcher, Kristina Jakobsson, Ying Li

Environment International · 2025-10 · 204 · 109794

DOI: 10.1016/j.envint.2025.109794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environment International, 2025-10. Verfasst von Axel G Andersson und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 414, 405 30 Got…. Hauptthemen laut MEDLINE: Fluorocarbons, Cholestyramine Resin, Probenecid, Environmental Pollutants. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Gothenburg Sahlgrenska Academy, Göteborgs Universitet, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Some per- and polyfluoroalkyl substances (PFAS) such as perfluorohexane sulfonic acid (PFHxS), perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) are very long-lived in humans, with serum half-lives of several years. In PFAS hot spots, such as Ronneby, Sweden, high exposures over time have led to markedly elevated serum PFAS levels, which may result in health risks as well as transfer to the next generation through pregnancy and breastfeeding. Bile acid sequestrants and organic anion transporter inhibitors are drug candidates for increasing PFAS elimination in humans. MATERIALS AND METHODS: This is a cross-over, clinical study in 10 individuals from Ronneby, Sweden. First, participants were given the bile acid sequestrant cholestyramine and the organic anion transporter inhibitor probenecid for 1 week each. Urinary and fecal concentrations were measured prior, during and after the administration. Then, the changes of serum PFAS concentrations during a 12-week intervention with the bile acid sequestrant colesevelam were compared to a control period. RESULTS: The study population was mainly exposed to PFHxS (serum mean 50 ng/mL, range 5.8-170), PFOS (serum mean 46 ng/mL, range 9.2-130) and PFOA (serum mean 2.2, range 0.7-4.4). Cholestyramine intervention increased the serum adjusted fecal PFOS concentrations by 23.1 times (95 %CI: 13.6, 39.2), while probenecid was associated with 0.79 times (95 %CI 0.63, 1.0) serum-adjusted urinary PFOS concentrations, compared to no intervention. The 12-week intervention with colesevelam resulted in a mean serum PFOS decline of 38 % (95 %CI -42, -34), compared to 2 % (95 %CI -8, 5) in the control period. The decline was smaller for PFHxS and PFOA. CONCLUSIONS: Bile acid sequestrants could be used for accelerating PFAS excretion in highly PFAS exposed individuals. Studies are needed to evaluate the risks, costs and benefits of using it for this purpose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorocarbonsCholestyramine ResinProbenecidEnvironmental PollutantsEnvironmental ExposureHumansSwedenCross-Over StudiesFemaleMaleAdultFecesAlkanesulfonic AcidsMiddle AgedCaprylatesSulfonic Acids

Stichwörter der Autor:innen

Bile acid sequestrantClinical trialCross-overPFASProbenecid

Substanzen

FluorocarbonsCholestyramine ResinProbenecidAlkanesulfonic Acidsperfluorooctane sulfonic acidEnvironmental Pollutantsperfluorooctanoic acidCaprylatesperfluorohexanesulfonic acidSulfonic Acids

Autor:innen und Institutionen

  • School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 414, 405 30 Gothenburg, Sweden. Electronic address: axel.andersson.2@gu.se.
  • School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Box 414, 405 30 Gothenburg, Sweden.
  • Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, Fakultetsgatan 1, 701 82 Örebro, Sweden.
  • Region Blekinge, Sweden.
  • Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Box 188, 221 00 Lund, Sweden.
  • Department of Public Health, Environments & Society, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Förderung

  • University of Gothenburg Sahlgrenska Academy
  • Göteborgs Universitet
  • Swedish Research Council
  • Svenska Forskningsrådet Formas

Zitieren

APA

Andersson, A. G., Xu, Y., Kärrman, A., Cederlund, J., Lindh, C. H., Pineda, D., Fletcher, T., Jakobsson, K., & Li, Y. (2025). Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid – cross-over trials in Ronneby, Sweden. Environment International, 204, 109794. https://doi.org/10.1016/j.envint.2025.109794

Vancouver

Andersson AG, Xu Y, Kärrman A, Cederlund J, Lindh CH, Pineda D, et al. Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid – cross-over trials in Ronneby, Sweden. Environment International. 2025;204:109794. doi:10.1016/j.envint.2025.109794

BibTeX
@article{Andersson2025,
  author = {Andersson, Axel G and Xu, Yiyi and Kärrman, Anna and Cederlund, Julia and Lindh, Christian H and Pineda, Daniela and Fletcher, Tony and Jakobsson, Kristina and Li, Ying},
  title = {Serum, urinary and fecal concentrations of perfluoroalkyl substances after interventions with cholestyramine/colesevelam and probenecid – cross-over trials in Ronneby, Sweden},
  journal = {Environment International},
  year = {2025},
  volume = {204},
  pages = {109794},
  doi = {10.1016/j.envint.2025.109794}
}
Kostenlos starten →